Searched for
MORPETH
£25 Cold Weather Payments triggered in UK as temperatures drop; Check full list of postcodes hereWhen a region's temperature drops to zero or lower for seven days in a row, Cold Weather Payments of £25 are given to qualifying households.- Piramal Pharma announces expansion of API manufacturing facilitiesPPS will also expand its potency footprint at its plant in Riverview, Michigan, while augmenting early development capabilities out of Enno...
- Piramal's pharma solution arm to invest $40 million in new technologyPiramal Enterprises' Pharma Solution division, a global leader in contract development and manufacturing said it plans to invest $40 mn in ...
- Piramal Healthcare to invest $11 mn in UK facilityWork on the new suite, which will house formulation, packaging coating and tableting equipment, will commence at the end of 2013.
- Piramal Healthcare posts Q3 net profit of Rs 8.52 crorePiramal Healthcare today posted consolidated net profit of Rs 8.52 crore for the third quarter ended December, 2011.
- Piramal to shift ops from UK plant, 85 may lose jobsPiramal has also opened a 30-day consultation period with around 85 employees at the plant, who are about to lose their jobs.
- SBI Cap recommends 'buy' on Piramal HealthcareSBI Capital has recommended ‘buy’ on Piramal Healthcare for a target price of Rs 360, an upside of 17 per cent over Thursday’s close at Rs ...
- NPIL net up 63% on custom manufacturing growthMumbai-Based pharmaceutical company Nicholas Piramal India (NPIL) has posted a 62.5% growth in net profit to Rs 87.3 crore in the second qu...
- Nicholas Piramal Q1 net profit down 32.5%Nicholas Piramal India Ltd has reported a net profit of Rs 34.39 crore for the quarter ended June 30, 2007.
- Foreign buys, new products pep up pharma sector: Buoyed by overseas acquisitions and new product launches in regulated markets, the pharma sector recorded exponential growth in the fourt...
- NPIL records Rs 55-cr net profit in Q4Buoyed by overseas acquisitions, Nicholas Piramal (NPIL) has reported a 52% jump in consolidated net sales to Rs 645.2 crore in the fourth ...
- Nicholas Piramal consolidated net at Rs 55.5 croreBuoyed by overseas acquisitions, domestic pharma major Nicholas Piramal .
- Nicholas Piramal Q3 PAT up 82 pc at Rs 43 crPharma major, Nicholas Piramal India has posted 82.39 per cent increase in profit after tax.
- Nicholas Piramal to develop Morvus technologiesNicholas Piramal (NPIL) has signed two licence agreements with the UK-based drug discovery company Morvus Technology.
- Nicholas Piramal Q2 net up 22 pc at Rs 67 crNicholas Piramal India Ltd has posted an increase of 22.14 per cent in net profit at Rs 67.06 crore for the quarter ended September 30.
- NPIL hopes to shrug off 2-year slumpIndia’s fourth largest pharma company, Nicholas Piramal (NPIL), is confident that it can reverse the trend as revenues from its contract ma...
- Nicholas Piramal acquires Pfizer's UK facilityNicholas Piramal India Ltd on Tuesday said it has completed the acquisition process of Pfizer Inc at Morpeth, UK, on asset purchase basis f...
- Nicholas Piramal to buy Pfizer's UK facilityThe UK subsidiary of NPIL has struck a deal to buy the manufacturing facility of Pfizer at Morpeth, UK, on an asset- purchase basis.
- Nicholas Piramal to acquire Pfizer's UK facilityNicholas Piramal India Ltd on Tuesday said its UK subsidiary has entered into an agreement to acquire the manufacturing facility of global ...
- NPIL Pharma to acquire Pfizer's UK facilityNicholas Piramal India Ltd on Thursday said its UK subsidiary has entered into an agreement to acquire the manufacturing facility of global...
Load More
